Qpex Biopharma, Inc. a Shionogi Group Company, is a resistance-focused infectious disease company on a mission to make both a dramatic and sustainable improvement in patient care. Leveraging a multi-faceted approach and a deep understanding of drug resistance mechanisms, we are creating novel products and development. strategies that overcome multi-drug resistance. We are advancing a robust portfolio of treatments that will bring innovation to antibiotic development and deliver the right treatments to the right patients in the right settings. During the previous decade, our team brought 4 antibiotic products to regulatory approvals, with an extensive record of working with public- private partnerships, including partnerships with the Biomedical Advanced Research and Development Authority (BARDA) that led to the first approved antimicrobial drug product under that program in 2017. San Diego-based Qpex was launched in 2018 with investments from New Enterprise Associates, Adams Street Partners, LYZZ Capital, Hatteras Venture Partners and Stanford University Daper Fund. In July 2023, Qpex was acquired by Shionogi, Inc and is now a Shionogi Group Company.
Company Details
- Employees
- 36
- Founded
- -
- Address
- 10075 Barnes Canyon Rd, San Diego,california 92121,united States
- Phone
- 858.500.8366
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- qpexbio.com
- Keywords
- Drug Discovery, Anti-Infective Therapies, Antibiotics, Drug Development, Drug Resistance, Microbiology, Boron Chemistry.
- HQ
- San Diego, California
Qpex Biopharma, Inc. Questions
Qpex Biopharma, Inc.'s helpline number is 858.500.8366
Qpex Biopharma, Inc.'s website is qpexbio.com
Qpex Biopharma, Inc.'s LinkedIn profile is https://www.linkedin.com/company/qpex-biopharma-inc
Qpex Biopharma, Inc. has
36 employees.
View email and phone details for 36
employees at Qpex Biopharma, Inc..
Qpex Biopharma, Inc.'s industry is
Biotechnology Research
Qpex Biopharma, Inc.'s top competitors are
Acurastem,
Bluejay Therapeutics,
M&b Sciences, Inc,
Light Horse Therapeutics,
Cionic,
Forest Neurotech,
Avenzo Therapeutics,
Biosapien,
Nuvig Therapeutics Inc.,
Curve Biosciences.
Qpex Biopharma, Inc.'s categories are Biotechnology Research
Qpex Biopharma, Inc.'s founding year is 2018
